The addition of pravastatin to idarubicin plus high-dose cytarabine is feasible, and potentially beneficial, in acute myeloid leukaemia

2007 ◽  
Vol &NA; (1588) ◽  
pp. 6
Author(s):  
&NA;
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
High Dose ◽  
High Dose Cytarabine ◽  
Acute Myeloid

scholarly journals Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high‐dose cytarabine and mitoxantrone

2020 ◽  
Author(s):  
Panagiotis Karagiannis ◽  
Winfried Alsdorf ◽  
Ann‐Christin Tallarek ◽  
Martin E. Blohm ◽  
Jennyfer Oelrich ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
High Dose ◽  
High Dose Cytarabine ◽  
Acute Myeloid

MITOZANTRONE AND HIGH-DOSE CYTARABINE IN REFRACTORY ADULT ACUTE MYELOID LEUKAEMIA

The Lancet ◽  
1985 ◽  
Vol 326 (8453) ◽  
pp. 508-509 ◽  
Author(s):  
W Hiddemann ◽  
H Kreutzmann ◽  
W.D Ludwig ◽  
H.C Aul ◽  
R Donhuijsen-Ant ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
High Dose ◽  
High Dose Cytarabine ◽  
Acute Myeloid

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study

1992 ◽  
Vol 82 (2) ◽  
pp. 337-346 ◽  
Author(s):  
Richard A. Larson ◽  
Roger S. Day ◽  
Nozar Azarnia ◽  
John M. Bennett ◽  
George Browman ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
High Dose ◽  
High Dose Cytarabine ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document